SG193486A1 - Pharmaceutical composition for treating hepatic disease - Google Patents

Pharmaceutical composition for treating hepatic disease Download PDF

Info

Publication number
SG193486A1
SG193486A1 SG2013069604A SG2013069604A SG193486A1 SG 193486 A1 SG193486 A1 SG 193486A1 SG 2013069604 A SG2013069604 A SG 2013069604A SG 2013069604 A SG2013069604 A SG 2013069604A SG 193486 A1 SG193486 A1 SG 193486A1
Authority
SG
Singapore
Prior art keywords
pharmaceutical composition
proanthocyanidin
liver
monomer units
improving
Prior art date
Application number
SG2013069604A
Other languages
English (en)
Inventor
Shau-Feng Chang
Chun-Hsien Ma
Kuo-Yi Yang
Shyh-Horng Lin
Chien-Tung Lin
Kai-Wen Huang
Original Assignee
Ind Tech Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ind Tech Res Inst filed Critical Ind Tech Res Inst
Publication of SG193486A1 publication Critical patent/SG193486A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
SG2013069604A 2011-03-22 2011-03-22 Pharmaceutical composition for treating hepatic disease SG193486A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2011/072045 WO2012126178A2 (zh) 2011-03-22 2011-03-22 减缓肝癌恶化、改善肝功能、改善肝纤维化、改善肝硬化、改善肝发炎及促进受损肝脏再生之药物组合物

Publications (1)

Publication Number Publication Date
SG193486A1 true SG193486A1 (en) 2013-10-30

Family

ID=46879777

Family Applications (1)

Application Number Title Priority Date Filing Date
SG2013069604A SG193486A1 (en) 2011-03-22 2011-03-22 Pharmaceutical composition for treating hepatic disease

Country Status (13)

Country Link
EP (1) EP2689777B1 (enExample)
JP (1) JP6166251B2 (enExample)
KR (2) KR101981378B1 (enExample)
CN (1) CN103442709B (enExample)
AU (1) AU2011362905B2 (enExample)
CA (1) CA2830616C (enExample)
DK (1) DK2689777T3 (enExample)
ES (1) ES2668785T3 (enExample)
NO (1) NO2689777T3 (enExample)
PL (1) PL2689777T3 (enExample)
RU (1) RU2561688C2 (enExample)
SG (1) SG193486A1 (enExample)
WO (1) WO2012126178A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140179774A1 (en) * 2012-12-26 2014-06-26 Industrial Technology Research Institute Methods for inhibition of shc-1/p66 to combat aging-related diseases
CN104774909A (zh) * 2014-10-17 2015-07-15 江苏大学 一种原花青素诱导肝癌细胞自噬性死亡的分析方法及应用
GB201909709D0 (en) * 2019-07-05 2019-08-21 Univ Liverpool Biomarkers for irritable bowel syndrome
WO2022080846A1 (ko) * 2020-10-13 2022-04-21 서울대학교병원 플라본을 포함하는 섬유증의 예방 또는 치료용 조성물
WO2022205137A1 (zh) * 2021-03-31 2022-10-06 贝尔克斯生技股份有限公司 高聚原花青素组合物及其应用
CN115010720B (zh) * 2022-06-02 2023-08-11 中国科学院昆明植物研究所 中甸艾中倍半萜二聚体及其药物组合物与其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6713506B2 (en) * 2000-10-11 2004-03-30 University Of South Florida Tea polyphenol esters and analogs thereof for cancer prevention and treatment
CN1443533A (zh) * 2002-03-07 2003-09-24 程彦杰 原花青素类化合物在用于制备解酒保肝产品方面的用途
TW200505468A (en) * 2003-08-11 2005-02-16 Suntory Ltd Agent for improving hepato-bililary dysfunction
WO2005074632A2 (en) * 2004-01-30 2005-08-18 Mars, Incorporated Methods and compositions for treating cancer
US20070054868A1 (en) * 2005-06-20 2007-03-08 The Trustees Of Columbia University In The City Of New York Synergistic polyphenol compounds, compositions thereof, and uses thereof
JP2008156265A (ja) * 2006-12-22 2008-07-10 Yamagata Prefecture Ａ型プロアントシアニジンオリゴマー画分及びその製造方法
JP2008195672A (ja) * 2007-02-14 2008-08-28 Okayama Univ 経口摂取用組成物及び経口摂取用組成物の製造方法
JP4822291B2 (ja) * 2008-03-14 2011-11-24 財団法人宮崎県産業支援財団 肝線維化抑制剤
TWI370736B (en) * 2008-12-31 2012-08-21 Ind Tech Res Inst Pharmaceutical composition for treating hepatitis b and heath food for inhibiting hepatitis b virus
CN101822372A (zh) * 2009-03-05 2010-09-08 财团法人工业技术研究院 用以治疗b型肝炎的药学组合物与抑制b型肝炎病毒的保健食品
CN101507730B (zh) * 2009-03-26 2011-01-26 复旦大学 表没食子儿茶素没食子酸酯与柔红霉素的组合物及其应用

Also Published As

Publication number Publication date
PL2689777T3 (pl) 2018-08-31
CN103442709A (zh) 2013-12-11
JP2014508785A (ja) 2014-04-10
WO2012126178A3 (zh) 2012-11-22
RU2013146602A (ru) 2015-04-27
KR101981378B1 (ko) 2019-05-22
ES2668785T3 (es) 2018-05-22
AU2011362905B2 (en) 2015-11-12
KR20140020966A (ko) 2014-02-19
KR20160143868A (ko) 2016-12-14
CA2830616C (en) 2017-02-21
CA2830616A1 (en) 2012-09-27
DK2689777T3 (en) 2018-05-22
CN103442709B (zh) 2018-10-19
EP2689777A4 (en) 2014-09-17
EP2689777A2 (en) 2014-01-29
NO2689777T3 (enExample) 2018-08-25
AU2011362905A1 (en) 2013-10-31
WO2012126178A2 (zh) 2012-09-27
RU2561688C2 (ru) 2015-08-27
JP6166251B2 (ja) 2017-07-19
EP2689777B1 (en) 2018-03-28

Similar Documents

Publication Publication Date Title
CA2830616C (en) Pharmaceutical composition for treating hepatic disease
Zhang et al. Cocrystals of natural products: Improving the dissolution performance of flavonoids using betaine
Wang et al. Polymethoxyflavones from citrus inhibited gastric cancer cell proliferation through inducing apoptosis by upregulating RARβ, both in vitro and in vivo
KR20040105530A (ko) 솔라눔속 식물의 수용성 추출물, 그 제조방법, 및 그수용성 추출물을 함유하는 약제학적 조성물
CN105963637B (zh) 隐丹参酮联合姜黄素在制备肿瘤治疗药物中的应用
Zhang et al. Protective action of pomegranate peel polyphenols in type 2 diabetic rats via the translocation of Nrf2 and FoxO1 regulated by the PI3K/Akt pathway
JP5636108B2 (ja) 癌を治療するための、レチノール、その前駆体または反応性生物および少なくとも１つのカモミール植物からの植物抽出液を含む組成物
US20100168221A1 (en) Pharmaceutical composition for treating hepatitis b virus and health food product having hepatitis b virus inhibiting effects
JP6837960B2 (ja) 化学療法に耐性である腫瘍の処置において用いるための、メラトニンおよびフラボノイド類を含む組成物
Pradhan et al. Cardioprotective effects of Rhododendron arboreum leaf extract against Doxorubicin-induced cardiotoxicity in Wistar rats by modulating electrocardiographic and cardiac biomarkers
CN105796638B (zh) 冬凌草甲素联合隐丹参酮在制备白血病治疗药物中的应用
TWI458487B (zh) 藥學組合物之用途
Kuo et al. Protection of Chinese olive fruit extract and its fractions against advanced glycation endproduct-induced oxidative stress and pro-inflammatory factors in cultured vascular endothelial and human monocytic cells
Kujawski et al. Basic studies on chemopreventive properties of quercetin and curcumin and other plant-origin compounds in ovarian cancer cells–A mini-review
Pei et al. Progress in research and application of silymarin
US20130123204A1 (en) Method for treating hepatitis b
Liang et al. Flavonoids in the Treatment of Non-small Cell Lung Cancer via Immunomodulation: Progress to Date
CN105833173B (zh) 冬凌草甲素联合姜黄素在制备白血病治疗药物中的应用
CN111529569B (zh) 一种治疗非酒精性脂肪肝的组合物及用途
HK1188720B (zh) 减缓肝癌恶化、改善肝功能、改善肝纤维化、改善肝硬化、改善肝发炎及促进受损肝脏再生之药物组合物
El-Said et al. Synergistic effect of avenanthramides and cisplatin co-treatment in Ehrlich ascites carcinoma-bearing mice
CN120643573A (zh) 一种预防缺血性脑卒中的药物及其制备方法
Ghaffar et al. The hematological and histological studies for the hepatoprotective-like effect of the hydromethanolic extract and the fractions of Viola serpens Wall.
TWI235664B (en) Extract from the leaves of Toona sinensis Roem., and the preparation process and uses thereof
US10220064B2 (en) Carbohydrate composition extracted from Panax ginseng and its use in the treatment of ischemic conditions